Back to Horizon Portfolio
Roundup-CV
Roundup-CV

Scientific Formulation

Roundup-CV

The Right Antibacterial Solution. Roundup-CV utilizes a 'Proven Dual Force' to permanently inactivate resistant pathogens, ensuring successful outcomes in post-operative and surgical conditions.

Molecular Composition

Cefuroxime Axetil 500 mg + Potassium Clavulanate 125 mg

Therapeutic Matrix

  • Beta-Lactamase Inhibition
  • Overcomes Bacterial Resistance
  • Broad Spectrum Coverage
  • Post-Surgical Protection

Mechanisms of Action

Cefuroxime Axetil

Inhibits bacterial cell wall synthesis to eliminate both gram-positive and gram-negative pathogens.

Clavulanic Acid

A mechanism-based inhibitor that permanently inactivates beta-lactamase enzymes, preventing them from destroying the antibiotic.

Clinical Advantage

Provides complete protection against resistant pathogens like Staphylococcus Aureus and Pseudomonas in acute ENT, Dental, and Wound infections.

Precision Healthcare for Everyone

BrandBrand